Subxiphoid Single-Port Robotic Thymectomy Using the Single-Port Robotic System versus VATS: A Multi-Institutional, Retrospective, and Propensity Score-Matched Study
Cancers · 15.08.2024 · 16 (16) · 2856
DOI: 10.3390/cancers16162856 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 15.08.2024. Verfasst von Jun Hee Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic and Cardiovascular Surgery, Guro Hospital, Korea University College of Medicine, Seoul 02841, Republic of Korea. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, Korea University, Korea Medical Device Development Fund grant funded by the Korean government.
Abstract (Originalsprache)
Subxiphoid thymectomy is a novel alternative to the transthoracic approach and sternotomy, with potential benefits, such as reduced postoperative pain and faster recovery. We previously reported the initial experience with subxiphoid single-port robotic-assisted thoracic surgery (SRATS) thymectomy using the single-port robotic system (SPS). However, the efficacy of this technique remains unknown. Thus, this study examined the multi-institutional experience with SRATS thymectomy and compared the perioperative outcomes of this technique to those of subxiphoid single-port video-assisted thoracic surgery (SVATS) thymectomy. The data of patients who underwent subxiphoid SRATS and SVATS thymectomy, performed by three thoracic surgeons at three institutions between September 2018 and May 2024, were retrospectively collected. In total, 110 patients were included, with 85 and 25 undergoing SRATS and SVATS thymectomy, respectively. After propensity score matching, 25 patients were included in each group. The SRATS group was associated with a lower conversion rate to multi-port surgery (0% vs. 20%, p = 0.05), shorter chest tube drainage duration (1.32 ± 0.75 vs. 2.00 ± 1.29 days, p = 0.003), and a shorter postoperative hospital stay (2.52 ± 1.00 vs. 5.08 ± 5.20 days, p = 0.003). Subxiphoid SRATS thymectomy using the SPS is feasible and is a good alternative to conventional thymectomy. Further studies are necessary to confirm its benefits.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic and Cardiovascular Surgery, Guro Hospital, Korea University College of Medicine, Seoul 02841, Republic of Korea.
- Department of Thoracic and Cardiovascular Surgery, Ansan Hospital, Korea University College of Medicine, Ansan 15355, Republic of Korea.
- Department of Thoracic and Cardiovascular Surgery, Anam Hospital, Korea University College of Medicine, Seoul 02841, Republic of Korea.
- Department of Biostatistics, Korea University College of Medicine, Seoul 02841, Republic of Korea.
ORCID-Profile: Jun Hee Lee, Tae Hyun Park, Byung Mo Gu, Younggi Jung, Eunjue Yi, Soon Young Hwang
Förderung
- Ministry of Science and ICT
- Korea University
- Korea Medical Device Development Fund grant funded by the Korean government
- Korea University Guro Hospital
Zitieren
APA
Lee, J. H., Hwang, J., Park, T. H., Gu, B. M., Jung, Y., Yi, E., Lee, S., Hwang, S. Y., Chung, J. H., & Kim, H. K. (2024). Subxiphoid Single-Port Robotic Thymectomy Using the Single-Port Robotic System versus VATS: A Multi-Institutional, Retrospective, and Propensity Score-Matched Study. Cancers, 16(16), 2856. https://doi.org/10.3390/cancers16162856
Vancouver
Lee JH, Hwang J, Park TH, Gu BM, Jung Y, Yi E, et al. Subxiphoid Single-Port Robotic Thymectomy Using the Single-Port Robotic System versus VATS: A Multi-Institutional, Retrospective, and Propensity Score-Matched Study. Cancers. 2024;16(16):2856. doi:10.3390/cancers16162856
BibTeX
@article{Lee2024,
author = {Lee, Jun Hee and Hwang, Jinwook and Park, Tae Hyun and Gu, Byung Mo and Jung, Younggi and Yi, Eunjue and Lee, Sungho and Hwang, Soon Young and Chung, Jae Ho and Kim, Hyun Koo},
title = {Subxiphoid Single-Port Robotic Thymectomy Using the Single-Port Robotic System versus VATS: A Multi-Institutional, Retrospective, and Propensity Score-Matched Study},
journal = {Cancers},
year = {2024},
volume = {16},
number = {16},
pages = {2856},
doi = {10.3390/cancers16162856}
}
EUVIMED